Pharmaceutical Commerce: June 2025 Interactive Digital Edition

The June issue of Pharmaceutical Commerce highlights the importance of embracing agility—and adaptable strategies—to better navigate industry challenges.

Alice Valder Curran outlines the steps manufacturers should take to better prepare for upcoming executive actions on drug pricing and market access.

The Asembia AXS25 Summit strives to explore ways to improve patient outcomes, especially for rare and complex diseases.

Claire Riches highlights inefficiencies in the current drug approval process, while outlining the role of payers and insurers in shifting toward data-driven approval framework.

Ways to address limitations while also enhancing the decision-making process.

The advantages and challenges associated with structuring a patient assistance program as a non-profit foundation.